A. Spanevello (Tradate, Italy), R. Louis (Liege, Belgium)
Serum periostin but not airway POSTN expression is reduced in smokers with asthma
N. Thomson, R. Chaudhuri, M. Spears, K. Nocka, S. Jelinsky, G. Miele, O. Hilmi, J. Haughney, C. McSharry (Glasgow, Aberdeen, United Kingdom; Cambridge, United States Of America)
|  |
TH2 specific biomarker profile determines steroid responsiveness in severe asthma
A. James, M. Kupczyk, J. Ono, S. Ohta, K. Izuhara, S. E. Dahlén (Stockholm, Sweden; Sagamihara, Japan)
| |
Methylated arginine derivatives can differ stable and unstable patients with COPD
T. Molnar, B. Süto, B. Biri, L. Nagy, S. Keki, I. Ruzsics (Pécs, Debrecen, Hungary)
|   |
Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD)
E. Dima, M. Kardara, H. Giannakopoulou, C. Roussos, N. Koulouris, N. Rovina (Athens, Greece)
| |
Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
J. Ji, I. von Schéele, B. Dahlén, J. Bergström, B. Billing, A. S. Lantz, K. Larsson, L. Palmberg (Stockholm, Sweden)
| |
Pro-surfactant protein B, a promising BAL biomarker of COPD progression in heavy smokers, is increased by budesonide/formoterol short-term therapy
A. Tam, S. J. Um, H. Coxson, S. Lam, S. Man, D. Sin (Vancouver, Canada)
| |
Assessment of ATP degradation in bronchoalveolar lavage fluid
Z. Lazar, M. Braun, A. Meyer, J. Beckert, I. Horvath, M. Idzko (Freiburg, Germany; Budapest, Hungary)
| |
Profiling the proteome of the lower airway respiratory tract lining fluid in chronic obstructive pulmonary disease
E. M. Bicer, B. Forbes, G. Somers, A. Blomberg, A. Behndig, I. Mudway (London, Stevenage, United Kingdom; Umea, Sweden)
| |